WARRINGTON, Pa., May 3, 2011 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO), announced that new data from a study using aerosolized KL4 surfactant demonstrated a significant improvement in lung function and survival when treating Acute Lung Injury (ALI) in a well-established preclinical model of this severe respiratory condition. The study was presented at the Pediatric Academic Societies (PAS) Annual Meeting, internationally recognized as the largest, most relevant medical meeting dedicated to pediatric research.
